All In MedTech

FDA Clearance Tracker · P000057

ASCENSION MCP

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Nov 19, 2001 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Nov 19, 2001

Approved

Time to decision

325 days

Received Dec 29, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P000057
Device name
ASCENSION MCP
Applicant location
Cordova, TN
Received
Dec 29, 2000
Decided
Nov 19, 2001
Decision
Approved
Expedited review
Yes, flagged as expedited in FDA's record.
Supplements
14 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NEG

FDA's approval statement

As written in FDA's record.

THIS DEVICE IS INDICATED FOR USE AS A TOTAL JOINT REPLACEMENT OF INDEX, LONG, RING, AND SMALL FINGER METACARPOPHALANGEAL JOINTS THAT EXHIBIT SYMPTOMS OF PAIN, LIMITED MOTION, OR INADEQUATE BONY ALIGNMENT (I.E., SUBLUXATION/DISLOCATION) SECONDRY TO ARTICULAR DESTRUCTION OR DEGENERATIVE DISEASE RELATED TO RHEUMATOID ARTHRITIS, LUPUS ERYTHEMATOSUS, OSTEOARTHRITIS, OR POST TRAUMATIC ARTHRITIS WHERE SOFT TISSUE RECONSTRUCTION CAN PROVIDE ADEQUATE STABILIZATION.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code NEG (Finger semi-constrained pyrolytic carbon uncemented prosthesis).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Smith & Nephew, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.